Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Ichnos Sciences strikes exclusive global deal with Astria Therapeutics for OX40 antibody portfolio Ichnos Sciences, a prominent clinical-stage biotechnology firm specializing in pioneering multispecific antibodies for oncology and under the ownership… byPallavi MadhirajuOctober 12, 2023